Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2024-04-29 00:00:00 ET · period of report 2024-04-28 · accession 0001127602-24-013555 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-29 | 2024-04-28 | LXRX | DEBBANE RAYMOND | Dir | M - OptEx | $0.00 | +8,032 | 1.35M | +0.6% | $0 |
| D | 2024-04-29 | 2024-04-28 | LXRX | DEBBANE RAYMOND | Dir | M - OptEx | $0.00 | -8,032 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-28 | M | A | 8,032 | $0.00 | 1,348,879 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2024-04-28 | M | D | 8,032 | $0.00 | 0 | D | $0.00 · — to — | 8,032 Common Stock | (F1) Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. (F2) Each restricted stock unit represents a contingent right to receive one share of common stock. |